2 results about "Human herpes virus" patented technology

The present invention is directed to the use of antiviral agents, in particular valomaciclovir stearate and its polymorph Form A, as well as H2G (omaciclovir) to treat multiple sclerosis in combination with other agents, as well as the use of these agents to treat diseases and conditions such as chronic mononucleosis, long COVID, chronic fatigue syndrome, fibromyalgia, Crohn's disease, ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus, Graves' disease, Alzheimer's disease, mesial temporal lobe seizures, Epstein-Barr-virus-linked autism, or an Epstein-Barr-virus-linked cancer.

This fatigue estimation device (100) comprises: a fatigue estimation model (12) constructed in advance on the basis of data including a relationship between a physiological quantity outside an activity period of a person and the amount of human herpesvirus outside the activity period, the fatigue estimation model (12) being capable of outputting a fatigue degree estimated from the corresponding amount of human herpesvirus in response to an input of biometric information; a physiological quantity measurement unit (20) for measuring a physiological quantity of a subject (user (99)); and a fatigue estimation unit (10) for outputting the fatigue degree of the subject on the basis of the measured physiological quantity by using the fatigue estimation model (12).